Detalhe da pesquisa
1.
Correction to: Engineered atherosclerosis-specific zinc ferrite nanocomplex-based MRI contrast agents.
J Nanobiotechnology;
17(1): 33, 2019 Feb 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30819190
2.
Effective Treatment of Metastatic Melanoma by Combining MAPK and PI3K Signaling Pathway Inhibitors.
Int J Mol Sci;
20(17)2019 Aug 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31470659
3.
Engineered atherosclerosis-specific zinc ferrite nanocomplex-based MRI contrast agents.
J Nanobiotechnology;
14: 6, 2016 Jan 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26775253
4.
Multifunctional iron bound lactoferrin and nanomedicinal approaches to enhance its bioactive functions.
Molecules;
20(6): 9703-31, 2015 May 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26016555
5.
Chimeric aptamers in cancer cell-targeted drug delivery.
Crit Rev Biochem Mol Biol;
46(6): 459-77, 2011 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21955150
6.
Recent advances in nanomedicine and survivin targeting in brain cancers.
Nanomedicine (Lond);
13(1): 105-137, 2018 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29161215
7.
Corrigendum: Topical Ophthalmic Formulation of Trichostatin A and SurR9-C84A for Quick Recovery Post-alkali Burn of Corneal Haze.
Front Pharmacol;
9: 1434, 2018.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30613201
8.
EpCAM Immunotherapy versus Specific Targeted Delivery of Drugs.
Cancers (Basel);
10(1)2018 Jan 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29329202
9.
Topical Ophthalmic Formulation of Trichostatin A and SurR9-C84A for Quick Recovery Post-alkali Burn of Corneal Haze.
Front Pharmacol;
8: 223, 2017.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28529481
10.
Erratum: "Quick chip assay using locked nucleic acid modified epithelial cell adhesion molecule and nucleolin aptamers for the capture of circulating tumor cells" [Biomicrofluidics 9(5), 054110 (2015)].
Biomicrofluidics;
11(4): 049901, 2017 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28868110
11.
Characterization and Molecular Mechanism of Peptide-Conjugated Gold Nanoparticle Inhibiting p53-HDM2 Interaction in Retinoblastoma.
Mol Ther Nucleic Acids;
9: 349-364, 2017 Dec 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29246314
12.
Survivin Modulators: An Updated Patent Review (2011-2015).
Recent Pat Anticancer Drug Discov;
11(2): 152-69, 2016.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26924735
13.
Ophthalmic Combination of SurR9-C84A and Trichostatin-A Targeting Molecular Pathogenesis of Alkali Burn.
Front Pharmacol;
7: 226, 2016.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27516741
14.
Theranostic multimodular potential of zinc-doped ferrite-saturated metal-binding protein-loaded novel nanocapsules in cancers.
Int J Nanomedicine;
11: 1349-66, 2016.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27099495
15.
Biodegradable Eri silk nanoparticles as a delivery vehicle for bovine lactoferrin against MDA-MB-231 and MCF-7 breast cancer cells.
Int J Nanomedicine;
11: 25-44, 2016.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26730188
16.
Molecular targets in arthritis and recent trends in nanotherapy.
Int J Nanomedicine;
10: 5407-20, 2015.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26345140
17.
LNA aptamer based multi-modal, Fe3O4-saturated lactoferrin (Fe3O4-bLf) nanocarriers for triple positive (EpCAM, CD133, CD44) colon tumor targeting and NIR, MRI and CT imaging.
Biomaterials;
71: 84-99, 2015 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26318819
18.
Oral administration of iron-saturated bovine lactoferrin-loaded ceramic nanocapsules for breast cancer therapy and influence on iron and calcium metabolism.
Int J Nanomedicine;
10: 4081-98, 2015.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26124661
19.
Competitive inhibition of survivin using a cell-permeable recombinant protein induces cancer-specific apoptosis in colon cancer model.
Int J Nanomedicine;
10: 1019-43, 2015.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25678789
20.
Quick chip assay using locked nucleic acid modified epithelial cell adhesion molecule and nucleolin aptamers for the capture of circulating tumor cells.
Biomicrofluidics;
9(5): 054110, 2015 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26487896